EP Biocomposites Balance Sheet Health
Financial Health criteria checks 4/6
EP Biocomposites has a total shareholder equity of ₹97.7M and total debt of ₹35.7M, which brings its debt-to-equity ratio to 36.6%. Its total assets and total liabilities are ₹156.8M and ₹59.1M respectively. EP Biocomposites's EBIT is ₹17.0M making its interest coverage ratio 14.3. It has cash and short-term investments of ₹13.2M.
Key information
36.6%
Debt to equity ratio
₹35.74m
Debt
| Interest coverage ratio | 14.3x |
| Cash | ₹13.22m |
| Equity | ₹97.70m |
| Total liabilities | ₹59.12m |
| Total assets | ₹156.81m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543595's short term assets (₹131.4M) exceed its short term liabilities (₹45.4M).
Long Term Liabilities: 543595's short term assets (₹131.4M) exceed its long term liabilities (₹13.7M).
Debt to Equity History and Analysis
Debt Level: 543595's net debt to equity ratio (23.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 543595's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 543595's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 543595's interest payments on its debt are well covered by EBIT (14.3x coverage).